Standard testing can miss some tumors, which are later diagnosed and called interval cancers. They’re often more aggressive ...

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat® KMT2A + MRD Assay and Software to its industry-leading ...

Results from a recently published randomized, double-blind, placebo-controlled clinical trial show that supplementation with Brightseed® BioMetaControl, containing the naturally occurring bioactive ...

The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) today released the sDHT Adoption Navigator, a comprehensive educational resource designed to help ...

Veeva Systems (NYSE: VEEV) today announced that 13 of the top 20 biopharmas have standardized on Veeva Link Key People to ...

OpenAI offering biotech firms free AI software in exchange for a share of drug revenues is like offering free Microsoft Word ...

A research team led by Prof. Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific Inc., has published a study in Nature that pinpoints the core functional circuit underlying ...

In its announcement, Medtronic said it plans to move forward with the CathWorks acquisition in a transaction valued at up to ...

Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...

Introduced in 2025, the DHNY Hall of Fame celebrates the trailblazers who set the standard for what's possible in digital health: companies that built, scaled, and endured, helping establish New York ...

A newly identified brain network may be the real driver of Parkinson’s—and precisely targeting it just delivered a major boost in symptom relief.

Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 million globally, is ...